![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | increases expression | EXP | | 6480464 | ethylene dichloride results in increased expression of IL20RB mRNA | CTD | PMID:28960355 | 17beta-estradiol | multiple interactions | ISO | RGD:1349896 | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of IL20RB mRNA | CTD | PMID:30165855 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of IL20RB mRNA | CTD | PMID:21570461 | 2-hydroxypropanoic acid | decreases expression | ISO | RGD:1349896 | 6480464 | Lactic Acid results in decreased expression of IL20RB mRNA | CTD | PMID:30851411 | 5-aza-2'-deoxycytidine | affects expression | ISO | RGD:1349896 | 6480464 | Decitabine affects the expression of IL20RB mRNA | CTD | PMID:23300844 | acrolein | multiple interactions | ISO | RGD:1349896 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of IL20RB mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of IL20RB mRNA | CTD | PMID:32699268 | alpha-pinene | multiple interactions | ISO | RGD:1349896 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of IL20RB mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of IL20RB mRNA | CTD | PMID:32699268 | antirheumatic drug | increases expression | ISO | RGD:1349896 | 6480464 | Antirheumatic Agents results in increased expression of IL20RB mRNA | CTD | PMID:24449571 | arsenous acid | increases expression | ISO | RGD:1349896 | 6480464 | Arsenic Trioxide results in increased expression of IL20RB mRNA | CTD | PMID:26705709 | belinostat | increases expression | ISO | RGD:1349896 | 6480464 | belinostat results in increased expression of IL20RB mRNA | CTD | PMID:26272509 | belinostat | multiple interactions | ISO | RGD:1349896 | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of IL20RB mRNA | CTD | PMID:27188386 | benzo[a]pyrene | decreases methylation | ISO | RGD:1349896 | 6480464 | Benzoapyrene results in decreased methylation of IL20RB exon, Benzoapyrene results in decreased methylation of IL20RB promoter | CTD | PMID:27901495 | bisphenol A | decreases expression | ISO | RGD:1566151 | 6480464 | bisphenol A results in decreased expression of IL20RB mRNA | CTD | PMID:25181051 | chloropicrin | affects expression | ISO | RGD:1349896 | 6480464 | chloropicrin affects the expression of IL20RB mRNA | CTD | PMID:26352163 | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IL20RB mRNA | CTD | PMID:20938992 | cisplatin | affects expression | ISO | RGD:1349896 | 6480464 | Cisplatin affects the expression of IL20RB mRNA | CTD | PMID:23300844 | cisplatin | increases expression | ISO | RGD:1349896 | 6480464 | Cisplatin results in increased expression of IL20RB mRNA | CTD | PMID:27392435 | copper atom | multiple interactions | ISO | RGD:1349896 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of IL20RB mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | RGD:1349896 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of IL20RB mRNA | CTD | PMID:20971185 | copper(II) sulfate | increases expression | ISO | RGD:1349896 | 6480464 | Copper Sulfate results in increased expression of IL20RB mRNA | CTD | PMID:19549813 | cyclosporin A | increases expression | ISO | RGD:1349896 | 6480464 | Cyclosporine results in increased expression of IL20RB mRNA | CTD | PMID:20106945, PMID:27989131 | dexamethasone | decreases expression | ISO | RGD:1349896 | 6480464 | Dexamethasone results in decreased expression of IL20RB mRNA | CTD | PMID:25047013 | dextran sulfate | multiple interactions | EXP | | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IL20RB mRNA | CTD | PMID:29950665 | diarsenic trioxide | increases expression | ISO | RGD:1349896 | 6480464 | Arsenic Trioxide results in increased expression of IL20RB mRNA | CTD | PMID:26705709 | dichloroacetic acid | increases expression | EXP | | 6480464 | Dichloroacetic Acid results in increased expression of IL20RB mRNA | CTD | PMID:28962523 | dorsomorphin | multiple interactions | ISO | RGD:1349896 | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... | CTD | PMID:27188386 | entinostat | increases expression | ISO | RGD:1349896 | 6480464 | entinostat results in increased expression of IL20RB mRNA | CTD | PMID:26272509, PMID:27188386 | entinostat | multiple interactions | ISO | RGD:1349896 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of IL20RB mRNA | CTD | PMID:27188386 | ferulic acid | multiple interactions | EXP | | 6480464 | ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL20RB mRNA] | CTD | PMID:31054998 | folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IL20RB mRNA | CTD | PMID:20938992 | hydrogen peroxide | affects expression | ISO | RGD:1349896 | 6480464 | Hydrogen Peroxide affects the expression of IL20RB mRNA | CTD | PMID:20044591 | imiquimod | multiple interactions | EXP | | 6480464 | ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL20RB mRNA] | CTD | PMID:31054998 | imiquimod | increases expression | EXP | | 6480464 | Imiquimod results in increased expression of IL20RB mRNA | CTD | PMID:31054998 | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IL20RB mRNA | CTD | PMID:20938992 | mercury dichloride | increases expression | ISO | RGD:1566151 | 6480464 | Mercuric Chloride results in increased expression of IL20RB mRNA | CTD | PMID:18496552 | ozone | multiple interactions | ISO | RGD:1349896 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of IL20RB mRNA more ... | CTD | PMID:32699268 | palbociclib | increases expression | ISO | RGD:1349896 | 6480464 | palbociclib results in increased expression of IL20RB mRNA | CTD | PMID:22869556 | panobinostat | increases expression | ISO | RGD:1349896 | 6480464 | panobinostat results in increased expression of IL20RB mRNA | CTD | PMID:26272509 | panobinostat | multiple interactions | ISO | RGD:1349896 | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of IL20RB mRNA | CTD | PMID:27188386 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of IL20RB mRNA | CTD | PMID:17562736 | perfluorononanoic acid | increases expression | ISO | RGD:1349896 | 6480464 | perfluorononanoic acid results in increased expression of IL20RB mRNA | CTD | PMID:32588087 | propanal | increases expression | ISO | RGD:1349896 | 6480464 | propionaldehyde results in increased expression of IL20RB mRNA | CTD | PMID:26079696 | Ptaquiloside | decreases expression | EXP | | 6480464 | ptaquiloside results in decreased expression of IL20RB mRNA | CTD | PMID:23274088 | quercetin | increases expression | ISO | RGD:1349896 | 6480464 | Quercetin results in increased expression of IL20RB mRNA | CTD | PMID:21632981 | rac-lactic acid | decreases expression | ISO | RGD:1349896 | 6480464 | Lactic Acid results in decreased expression of IL20RB mRNA | CTD | PMID:30851411 | SB 431542 | multiple interactions | ISO | RGD:1349896 | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... | CTD | PMID:27188386 | silver atom | decreases expression | EXP | | 6480464 | Silver results in decreased expression of IL20RB mRNA | CTD | PMID:27131904 | silver(0) | decreases expression | EXP | | 6480464 | Silver results in decreased expression of IL20RB mRNA | CTD | PMID:27131904 | simvastatin | increases expression | ISO | RGD:1349896 | 6480464 | Simvastatin results in increased expression of IL20RB mRNA | CTD | PMID:17428261 | sodium arsenite | decreases expression | ISO | RGD:1349896 | 6480464 | sodium arsenite results in decreased expression of IL20RB mRNA | CTD | PMID:28595984 | sodium arsenite | increases expression | ISO | RGD:1349896 | 6480464 | sodium arsenite results in increased expression of IL20RB mRNA | CTD | PMID:29301061 | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of IL20RB mRNA | CTD | PMID:27760801 | titanium dioxide | multiple interactions | EXP | | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IL20RB mRNA | CTD | PMID:29950665 | trichostatin A | increases expression | ISO | RGD:1349896 | 6480464 | trichostatin A results in increased expression of IL20RB mRNA | CTD | PMID:24935251 | urethane | increases expression | ISO | RGD:1349896 | 6480464 | Urethane results in increased expression of IL20RB mRNA | CTD | PMID:28818685 | valproic acid | increases expression | ISO | RGD:1349896 | 6480464 | Valproic Acid results in increased expression of IL20RB mRNA | CTD | PMID:24935251 | valproic acid | multiple interactions | ISO | RGD:1349896 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of IL20RB mRNA | CTD | PMID:27188386 | vorinostat | multiple interactions | ISO | RGD:1349896 | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of IL20RB mRNA | CTD | PMID:27188386 | vorinostat | increases expression | ISO | RGD:1349896 | 6480464 | vorinostat results in increased expression of IL20RB mRNA | CTD | PMID:26272509 | |